The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The Population Dynamics and Control of Tuberculosis
Abstract
More than 36 million patients have been successfully treated via the World Health Organization’s strategy for tuberculosis (TB) control since 1995. Despite predictions of a decline in global incidence, the number of new cases continues to grow, approaching 10 million in 2010. Here we review the changing relationship between the causative agent, Mycobacterium tuberculosis , and its human host and examine a range of factors that could explain the persistence of TB. Although there are ways to reduce susceptibility to infection and disease, and a high-efficacy vaccine would boost TB prevention, early diagnosis and drug treatment to interrupt transmission remain the top priorities for control. Whatever the technology used, success depends critically on the social, institutional, and epidemiological context in which it is applied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Infectious Diseases of Humans: Dynamics and Control
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-174_4 · Cited by 7,746
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
Self-citationGandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., & Young, D. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,422
Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update
Pai, M., Zwerling, A., & Menzies, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00241 · Cited by 1,339
Mackay, J. M., & Eriksen, M. P. (2002) · Medical Entomology and Zoology · Cited by 1,322
Barrett, C. B. (2010) · Science · doi:10.1126/science.1182768 · Cited by 1,313
Tuberculosis and diabetes mellitus: convergence of two epidemics
Dooley, K. E., & Chaisson, R. E. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70282-8 · Cited by 932
Ramachandran, A., Wan Ma, R. C., & Snehalatha, C. (2010) · The Lancet · doi:10.1016/s0140-6736(09)60937-5 · Cited by 782
Treatment of latent tuberculosis infection in HIV infected persons
Akolo, C., Adetifa, I., Shepperd, S., & Volmink, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000171.pub3 · Cited by 713
Gagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712
The state of the world population 2007: unleashing the potential of urban growth.
Lahariya, C. (2008) · PubMed · Cited by 694
The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis
Gagneux, S., Long, C. D., Small, P. M., Van, T., Schoolnik, G. K., & Bohannan, B. J. M. (2006) · Science · doi:10.1126/science.1124410 · Cited by 627
A Nationally Representative Case–Control Study of Smoking and Death in India
Jha, P., Jacob, B., Gajalakshmi, V., Gupta, P. C., Dhingra, N., Kumar, R., Sinha, D. N., Dikshit, R. P., Parida, D. K., Kamadod, R., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0707719 · Cited by 554
Caws, M., Thwaites, G., Dunstan, S., Hawn, T. R., Thi Ngoc Lan, N., Thuong, N. T. T., Stepniewska, K., Huyen, M. N. T., Bang, N. D., Huu Loc, T., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000034 · Cited by 498
Gajalakshmi, V., Peto, R., Kanaka, T. S., & Jha, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14109-8 · Cited by 481
Prospects for worldwide tuberculosis control under the WHO DOTS strategy
Dye, C., Garnett, G. P., Sleeman, K., & Williams, B. G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03199-7 · Cited by 462
Self-citationA consistent log-linear relationship between tuberculosis incidence and body mass index
Lonnroth, K., Williams, B. G., Cegielski, P., & Dye, C. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp308 · Cited by 455
Self-citationZaridze, D., Brennan, P., Boreham, J., Boroda, A., Karpov, R., Lazarev, A., Konobeevskaya, I., Igitov, V., Terechova, T., Boffetta, P., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61034-5 · Cited by 454
Parwati, I., van Crevel, R., & van Soolingen, D. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70330-5 · Cited by 383
Hazbón, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., García-García, L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00112-06 · Cited by 374
Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence
Stevenson, C. R., Forouhi, N. G., Roglic, G., Williams, B. G., Lauer, J. A., Dye, C., & Unwin, N. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-234 · Cited by 365
Self-citationTrends in tuberculosis incidence and their determinants in 134 countries
Dye, C., Lönnroth, K., Jaramillo, E., Williams, B., & Raviglione, M. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.058453 · Cited by 364
Self-citationEpidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
Abu-Raddad, L. J., Sabatelli, L., Achterberg, J. T., Sugimoto, J. D., Longini, I. M., Dye, C., & Halloran, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901720106 · Cited by 348
Self-citationLin, H.-H., Murray, M., Cohen, T., Colijn, C., & Ezzati, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61345-8 · Cited by 302
de Jong, B. C., Hill, P. C., Aiken, A., Awine, T., Antonio, M., Adetifa, I. M., Jackson‐Sillah, D. J., Fox, A., DeRiemer, K., Gagneux, S., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/591504 · Cited by 289
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness
Cohen, T., & Murray, M. (2004) · Nature Medicine · doi:10.1038/nm1110 · Cited by 277
The equilibria that allow bacterial persistence in human hosts
Blaser, M. J., & Kirschner, D. (2007) · Nature · doi:10.1038/nature06198 · Cited by 236
Myths and misconceptions: the origin and evolution of Mycobacterium tuberculosis
Smith, N. H., Hewinson, R. G., Kremer, K., Brosch, R., & Gordon, S. V. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2165 · Cited by 229
Kranzer, K., Houben, R. M. G. J., Glynn, J. R., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70326-3 · Cited by 148
Past, present and future directions in human genetic susceptibility to tuberculosis
Möller, M., de Wit, E., & Hoal, E. G. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00600.x · Cited by 130
Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease
Malik, S., Abel, L., Tooker, H. R., Poon, A. H., Simkin, L., Girard, M., Adams, G. J., Starke, J. R., Smith, K. C., Graviss, E. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503368102 · Cited by 126
Lethal interaction: the colliding epidemics of tobacco and tuberculosis
Pai, M., Mohan, A., Dheda, K. U. J., Leung, C. C., Yew, W. W., Christopher, D. J., & Sharma, S. K. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.3.385 · Cited by 96
Grzybowski, S., Styblo, K., & Dorken, E. (1976) · Tubercle · doi:10.1016/0041-3879(76)90059-3 · Cited by 83
McEvoy, C., van Helden, P. D., Warren, R. M., & van Pittius, N. C. G. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-237 · Cited by 78
[Epidemiology of tuberculosis].
Bermejo, M. A. M., Clavera, I., Michel de la Rosa, F., et al. (2007) · PubMed · Cited by 66
Prammananan, T., Cheunoy, W., Taechamahapun, D., Yorsangsukkamol, J., Phunpruch, S., Phdarat, P., Leechawengwong, M., & Chaiprasert, A. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01951.x · Cited by 58
Historical Intensity of Natural Selection for Resistance to Tuberculosis
Lipsitch, M., & Sousa, A. O. (2002) · Genetics · doi:10.1093/genetics/161.4.1599 · Cited by 52
The nutrition transition in Cuba in the nineties: an overview
Rodríguez-Ojea, A., Jiménez, S., Berdasco, A., & Esquivel, M. (2002) · Public Health Nutrition · doi:10.1079/phn2001284 · Cited by 47
Vynnycky, E., Borgdorff, M. W., Leung, C. C., et al. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807008552 · Cited by 45
Reichman and Hershfield's Tuberculosis: A Comprehensive, International Approach
Reichman, L. B., & Hershfield, E. S. (2006) · Medical Entomology and Zoology · Cited by 30
Slow Elimination of Multidrug-Resistant Tuberculosis
Dye, C., & Williams, B. G. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000346 · Cited by 23
Self-citation
Cited by
The challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042
HIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
Narasimhan, P., Wood, J., MacIntyre, C. R., & Mathai, D. (2013) · Pulmonary Medicine · doi:10.1155/2013/828939 · Cited by 731
Mycobacterium tuberculosis: success through dormancy
Gengenbacher, M., & Kaufmann, S. H. E. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00331.x · Cited by 696
Minisci reactions: Versatile CH-functionalizations for medicinal chemists
Duncton, M. A. J. (2011) · MedChemComm · doi:10.1039/c1md00134e · Cited by 607
Metadata
- Authors
- Dye, C., & Williams, B. G.
- Venue
- Science
- Published
- 2010-05-14
- Volume
- 328
- Issue
- 5980
- Pages
- 856-861
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2000206958
- Cited by
- 604
- References
- 43
- FWCI
- 46.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.